FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998021211> ?p ?o ?g. }

• W2998021211 endingPage "327" @default.
• W2998021211 startingPage "311" @default.
• W2998021211 abstract "Breast cancer patients are at high risk for bone metastasis. Metastatic bone disease is a major clinical problem that leads to a reduction in mobility, increased risk of pathologic fracture, severe bone pain, and other skeletal-related events. The transcription factor Gli2 drives expression of parathyroid hormone-related protein (PTHrP), which activates osteoclast-mediated bone destruction, and previous studies showed that Gli2 genetic repression in bone-metastatic tumor cells significantly reduces tumor-induced bone destruction. Small molecule inhibitors of Gli2 have been identified; however, the lipophilicity and poor pharmacokinetic profile of these compounds have precluded their success in vivo. In this study, we designed a bone-targeted nanoparticle (BTNP) comprising an amphiphilic diblock copolymer of poly[(propylene sulfide)-block-(alendronate acrylamide-co-N,N-dimethylacrylamide)] [PPS-b-P(Aln-co-DMA)] to encapsulate and preferentially deliver a small molecule Gli2 inhibitor, GANT58, to bone-associated tumors. The mol % of the bisphosphonate Aln in the hydrophilic polymer block was varied in order to optimize BTNP targeting to tumor-associated bone by a combination of nonspecific tumor accumulation (presumably through the enhanced permeation and retention effect) and active bone binding. Although 100% functionalization with Aln created BTNPs with strong bone binding, these BTNPs had highly negative zeta-potential, resulting in shorter circulation time, greater liver uptake, and less distribution to metastatic tumors in bone. However, 10 mol % of Aln in the hydrophilic block generated a formulation with a favorable balance of systemic pharmacokinetics and bone binding, providing the highest bone/liver biodistribution ratio among formulations tested. In an intracardiac tumor cell injection model of breast cancer bone metastasis, treatment with the lead candidate GANT58-BTNP formulation decreased tumor-associated bone lesion area 3-fold and increased bone volume fraction in the tibiae of the mice 2.5-fold. Aln conferred bone targeting to the GANT58-BTNPs, which increased GANT58 concentration in the tumor-associated bone relative to untargeted NPs, and also provided benefit through the direct antiresorptive therapeutic function of Aln. The dual benefit of the Aln in the BTNPs was supported by the observations that drug-free Aln-containing BTNPs improved bone volume fraction in bone-tumor-bearing mice, while GANT58-BTNPs created better therapeutic outcomes than both unloaded BTNPs and GANT58-loaded untargeted NPs. These findings suggest GANT58-BTNPs have potential to potently inhibit tumor-driven osteoclast activation and resultant bone destruction in patients with bone-associated tumor metastases." @default.
• W2998021211 created "2020-01-10" @default.
• W2998021211 creator A5006495466 @default.
• W2998021211 creator A5023681130 @default.
• W2998021211 creator A5039586000 @default.
• W2998021211 creator A5042173290 @default.
• W2998021211 creator A5046849690 @default.
• W2998021211 creator A5047832949 @default.
• W2998021211 creator A5058207517 @default.
• W2998021211 creator A5062551098 @default.
• W2998021211 creator A5075425730 @default.
• W2998021211 creator A5075476806 @default.
• W2998021211 creator A5075794128 @default.
• W2998021211 creator A5088794614 @default.
• W2998021211 date "2020-01-02" @default.
• W2998021211 modified "2023-10-15" @default.
• W2998021211 title "Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction" @default.
• W2998021211 cites W1574492943 @default.
• W2998021211 cites W1761183838 @default.
• W2998021211 cites W1809723326 @default.
• W2998021211 cites W1957203406 @default.
• W2998021211 cites W1968983034 @default.
• W2998021211 cites W1971219606 @default.
• W2998021211 cites W1973142147 @default.
• W2998021211 cites W1981408916 @default.
• W2998021211 cites W1986898983 @default.
• W2998021211 cites W1994942442 @default.
• W2998021211 cites W1997726224 @default.
• W2998021211 cites W1997823019 @default.
• W2998021211 cites W1998464768 @default.
• W2998021211 cites W2008080609 @default.
• W2998021211 cites W2021397298 @default.
• W2998021211 cites W2024608190 @default.
• W2998021211 cites W2025446473 @default.
• W2998021211 cites W2029515264 @default.
• W2998021211 cites W2032654453 @default.
• W2998021211 cites W2033857478 @default.
• W2998021211 cites W2043074430 @default.
• W2998021211 cites W2044288544 @default.
• W2998021211 cites W2047336909 @default.
• W2998021211 cites W2054635074 @default.
• W2998021211 cites W2055802170 @default.
• W2998021211 cites W2055928148 @default.
• W2998021211 cites W2059293303 @default.
• W2998021211 cites W2059456940 @default.
• W2998021211 cites W2063699543 @default.
• W2998021211 cites W2064093384 @default.
• W2998021211 cites W2072268794 @default.
• W2998021211 cites W2078057254 @default.
• W2998021211 cites W2079184456 @default.
• W2998021211 cites W2082445702 @default.
• W2998021211 cites W2088342479 @default.
• W2998021211 cites W2089220360 @default.
• W2998021211 cites W2091226449 @default.
• W2998021211 cites W2096662041 @default.
• W2998021211 cites W2102969047 @default.
• W2998021211 cites W2110321605 @default.
• W2998021211 cites W2110707581 @default.
• W2998021211 cites W2111151753 @default.
• W2998021211 cites W2117289416 @default.
• W2998021211 cites W2120462866 @default.
• W2998021211 cites W2122786185 @default.
• W2998021211 cites W2127410754 @default.
• W2998021211 cites W2132118277 @default.
• W2998021211 cites W2134660260 @default.
• W2998021211 cites W2136678826 @default.
• W2998021211 cites W2137302084 @default.
• W2998021211 cites W2157031202 @default.
• W2998021211 cites W2161004176 @default.
• W2998021211 cites W2161796038 @default.
• W2998021211 cites W2168458013 @default.
• W2998021211 cites W2169096250 @default.
• W2998021211 cites W2183777073 @default.
• W2998021211 cites W2188700252 @default.
• W2998021211 cites W2306899626 @default.
• W2998021211 cites W2306994132 @default.
• W2998021211 cites W2317410507 @default.
• W2998021211 cites W2323137482 @default.
• W2998021211 cites W2381577556 @default.
• W2998021211 cites W2513830982 @default.
• W2998021211 cites W2531068218 @default.
• W2998021211 cites W2581453412 @default.
• W2998021211 cites W2592322859 @default.
• W2998021211 cites W2599900557 @default.
• W2998021211 cites W2605515812 @default.
• W2998021211 cites W2606588527 @default.
• W2998021211 cites W2617012077 @default.
• W2998021211 cites W2620093920 @default.
• W2998021211 cites W2623014794 @default.
• W2998021211 cites W2735185789 @default.
• W2998021211 cites W2735592130 @default.
• W2998021211 cites W2756463246 @default.
• W2998021211 cites W2766728579 @default.
• W2998021211 cites W2766964027 @default.
• W2998021211 cites W2800716076 @default.
• W2998021211 cites W2803099266 @default.
• W2998021211 cites W2887799451 @default.
• W2998021211 cites W2906587283 @default.

• next